Completed PHASE2 INTERVENTIONAL 2-arm NCT03647813

Effects of Photobiomodulation in Salivary Analysis of Chronic Renal Failure Patients

Effects of Photobiomodulation Therapy in Salivary Analysis of Chronic Renal Failure Patients Undergoing Hemodialysis: a Randomized Placebo-controlled Trial

Sponsor: University of Nove de Julho

Conditions Chronic Renal Failure Xerostomia

Interventions Photobiomodulation Placebo

Updated 4 times since 2018 Last updated: Aug 27, 2018 Started: Jul 1, 2016 Primary completion: Sep 15, 2017 Completion: Sep 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03647813, this PHASE2 trial focuses on Chronic Renal Failure and Xerostomia and remains completed. Sponsored by University of Nove de Julho, it has been updated 4 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Sep 2018 — Jan 2021 [monthly]

Completed PHASE2

First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Nove de Julho

Data source: University of Nove de Julho

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.